Canaccord initiated coverage of Wave Life Sciences (WVE) with a Buy rating and $19 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE:
- Oppenheimer Predicts Up to 590% Rally for These 2 ‘Strong Buy’ Stocks
- Wave Life Sciences Poised for Growth: Buy Rating Affirmed Amid Upcoming Catalysts
- Wave Life Sciences Earnings Call: Clinical Advances Amid Financial Challenges
- Wave Life Sciences Advances RNA Medicine Pipeline
- Wave Life Sciences reports Q2 EPS (31c), consensus (28c)